Stéphane Legastelois
Directeur/Bestuurslid bij BIOCORP
Profiel
Stéphane Legastelois is currently the Chairman & CEO of Indicia Production SASU, CEO of Platine Pharma Services SAS, Chairman of Transcure Bioservices SAS, Chairman of Indicia Développement SA, Chairman of Indicia Participations, Chairman of 33 Californie SAS (Lentilly), Chairman of Mexbrain SAS, Chairman of Simba Sante 3 SAS, Director of BioAster, Independent Director of BIOCORP Production SA, Director of Jalon Therapeutics, and Co-Manager of Camilla SNC.
He has previously held positions as Chairman of Mabdesign Association, Director of Boiron SA, and Manager of Sci La Parliere.
Actieve functies van Stéphane Legastelois
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOCORP | Directeur/Bestuurslid | 12-05-2015 |
Indicia Production SASU
 Indicia Production SASU BiotechnologyHealth Technology Indicia Production SASU provides biotechnology research and development services. It manufactures ready-to-use microbiological media for the food and pharmaceutical industry. The company was founded in 1993 and is headquartered in Saint-Genis-l'Argentiere, France. | Algemeen Directeur | - |
| Indicia Développement SA | Voorzitter | - |
Platine Pharma Services SAS
 Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Algemeen Directeur | - |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Directeur/Bestuurslid | - |
Indicia Participations
 Indicia Participations Financial ConglomeratesFinance Indicia Participations functions as an investment holding French company. The private company is based in Saint-Genis-l'Argentière, France. | Voorzitter | - |
SCI CALIFORNIE
 SCI CALIFORNIE Real Estate DevelopmentFinance SCI CALIFORNIE is a French company that leases real estate properties. | Corporate Officer/Principal | - |
| 33 Californie SAS (Lentilly) | Voorzitter | 02-11-2004 |
Mexbrain SAS
 Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Voorzitter | - |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Eerdere bekende functies van Stéphane Legastelois
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOCORP | Health Technology |
| BOIRON | Health Technology |
| Bedrijven in privébezit | 14 |
|---|---|
Indicia Production SASU
Indicia Production SASU BiotechnologyHealth Technology Indicia Production SASU provides biotechnology research and development services. It manufactures ready-to-use microbiological media for the food and pharmaceutical industry. The company was founded in 1993 and is headquartered in Saint-Genis-l'Argentiere, France. | Health Technology |
| Indicia Développement SA | |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Health Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Commercial Services |
Mabdesign Association
 Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Commercial Services |
| Sci La Parliere | |
Indicia Participations
Indicia Participations Financial ConglomeratesFinance Indicia Participations functions as an investment holding French company. The private company is based in Saint-Genis-l'Argentière, France. | Finance |
SCI CALIFORNIE
SCI CALIFORNIE Real Estate DevelopmentFinance SCI CALIFORNIE is a French company that leases real estate properties. | Finance |
| 33 Californie SAS (Lentilly) | |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Health Technology |
Transcure Bioservices SAS
 Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Commercial Services |
| Simba Sante 3 SAS | Finance |
Jalon Therapeutics
 Jalon Therapeutics Pharmaceuticals: MajorHealth Technology Jalon Therapeutics is a French company that aims to develop innovative therapies to treat cancer by inactivating vital tumor signaling pathways. Jalon Therapeutics is based in Paris, France and manages an extensive candidate portfolio of drug candidates infused by its unique expertise in AAC-11 biology. The company leverages their deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. The company's lead candidate, JRT39, is the first-in-class drug developed for the treatment of hard-to-treat cancers. The company is building a drug discovery platform to develop other candidates derived from AAC-11 and AAC-11 partners for the treatment of cancer. Jalon Therapeutics raised a pre-seed in 2022, leveraged by non-dilutive and quasi-equity fundings from public institutions. The company's growth ambition is to raise a seed immediately followed by a series A to finance up to the clinical proof of concept of their lead candidate JRT39. The company was founded in 2021 by Jérôme Tiollier, Jean-Luc Poyet, Prof. Martine Bagot, Prof. Hervé Dombret, Jean-Christophe Rain, and Philippe Salphati. The CEO is David Loison. | Health Technology |
Camilla SNC
 Camilla SNC Financial ConglomeratesFinance Part of Société Générale SA, Camilla SNC is an investment holding French company. The company is based in Puteaux, France and was founded in 2005. | Finance |
